<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05035771</url>
  </required_header>
  <id_info>
    <org_study_id>Essex CTC IMPACT PAD</org_study_id>
    <nct_id>NCT05035771</nct_id>
  </id_info>
  <brief_title>The IMPACT PAD Study</brief_title>
  <acronym>IMPACT PAD</acronym>
  <official_title>A Safety and Feasibility Study of Intraprocedural Physiology Measurements During Peripheral Endovascular Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mid and South Essex NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mid and South Essex NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Defining the role of intraprocedural physiology measurements in peripheral endovascular&#xD;
      treatment&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endovascular treatment for peripheral arterial disease is commonly performed for claudication&#xD;
      or critical limb threatening ischaemia (ischaemic rest pain, foot ulcer or gangrene). Disease&#xD;
      is generally identified using Ankle Brachial Pressure Index or Toe Brachial Pressure Index&#xD;
      and then lesions delineated using Doppler ultrasound or CT angiography. Clinical severity is&#xD;
      staged using absolute walking distance (metres) in claudicants or the Society for Vascular&#xD;
      Surgery wIfI (wound, ischaemia, foot infection) score in critical limb threatening ischaemia&#xD;
      patients.&#xD;
&#xD;
      Intra-procedural lesion assessment and quality control is currently performed anatomically&#xD;
      using angiography alone, with a few centres using pullback pressures across a lesion to give&#xD;
      supplementary trans-lesional gradients or intravascular ultrasound (IVUS) to give pre and&#xD;
      post intervention diameter and vessel area measurements. No direct or quantitative assessment&#xD;
      of flow, or pressure normalisation across lesions is currently performed during interventions&#xD;
      to improve blood flow to the leg.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">January 6, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 6, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pressure wire measurements</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Pressure wire measurements</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pressure wire measurement in peripheral vascular disease</intervention_name>
    <description>The aim of IMPACT PAD is to examine the safety and feasibility of intraprocedural flow, pressure and resistance rate changes to help predict the success of a peripheral endovascular intervention.</description>
    <arm_group_label>Pressure wire measurements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age&#xD;
&#xD;
          -  Peripheral arterial stenosis scheduled for endovascular treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; 18 year of age&#xD;
&#xD;
          -  Unable to give informed consent&#xD;
&#xD;
          -  Estimated GFR â‰¤30 mL/min&#xD;
&#xD;
          -  Dialysis dependent&#xD;
&#xD;
          -  Unable to receive antiplatelets or periprocedural anticoagulation&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Contraindication to adenosine (severe asthma or COPD)&#xD;
&#xD;
          -  WIfI ulcer score &lt;2 (no exposed bone)&#xD;
&#xD;
          -  WIfI infection score &lt;2 (skin and subcutaneous tissues only)&#xD;
&#xD;
          -  WIfI gangrene score &lt;3 (limited to digits)&#xD;
&#xD;
          -  COVID-19 positive&#xD;
&#xD;
          -  NYHA IV heart failure&#xD;
&#xD;
          -  Contra-indication to adenosine including arrhythmia, asthma or allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ankur Thapar, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mid and South Essex NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ankur Thapar, MBBS, FRCS</last_name>
    <phone>+44 7393 743 954</phone>
    <email>a.thapar09@imperial.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Keeble, MD</last_name>
    <phone>01268524900</phone>
    <email>thomas.keeble2@nhs.net</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>August 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

